Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2017-06-20 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
中信建投证券股份有限公司关于公司发行股份购买资产及重大资产出售暨关联交易资产过户情况之独立财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor's Verification Opinion" related to a major asset restructuring involving issuance of shares to purchase assets and significant asset sales by Chengdu Tianxing Instrument Co., Ltd. It includes detailed descriptions of the transaction, decision and approval procedures, asset transfer and share issuance handling, and compliance with regulatory approvals from the China Securities Regulatory Commission (CSRC). The document is lengthy (15,000 characters) and contains substantive financial and procedural details about the asset purchase and sale, share issuance, and related corporate governance matters. It is not a simple announcement or certification but a comprehensive advisory report on a major asset restructuring transaction. This fits the category of Audit Report / Information (AR), which includes standalone audit or verification reports related to major transactions and applied accounting principles, distinct from full annual or interim reports. Therefore, the document is best classified as AR with high confidence. FY 2016
2017-06-20 Chinese
关于发行股份购买资产及重大资产出售暨关联交易的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding the issuance of shares to purchase assets and a major asset sale, including related party transactions. It mentions regulatory approval from the China Securities Regulatory Commission and details about asset transfer completion and ongoing procedures. The content focuses on updates about a financing and asset transaction rather than the full transaction documents or financial statements. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is CAP with high confidence.
2017-06-19 Chinese
关于召开2016年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2016 Annual General Meeting (AGM) of Chengdu Tianxing Instrument Co., Ltd. It includes details about the meeting date, voting procedures, agenda items such as the 2016 board report, supervisory report, financial report, profit distribution plan, and annual report summary. It also contains instructions for shareholders on how to participate and vote, including proxy authorization forms. The document does not contain the actual financial statements or detailed reports but rather the notification and procedural information for the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length is about 5296 characters, consistent with a detailed AGM notice rather than a full annual report or financial report.
2017-06-07 Chinese
第七届董事会第十六次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by Chengdu Tianxing Instrument Co., Ltd. It details the convening of the 7th Board's 16th extraordinary meeting, the voting results, and the decision to hold the 2016 Annual General Meeting on June 29, 2017. There is no financial data, audit information, or detailed report content. The document is an announcement of a board decision, not the report itself. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management decisions, not a full report or regulatory filing.
2017-06-07 Chinese
关于公司重大资产重组及发行股份购买资产事项获得中国证监会核准批文的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Chengdu Tianxing Instrument Co., Ltd. regarding the approval by the China Securities Regulatory Commission (CSRC) of a major asset restructuring and issuance of shares to purchase assets. It includes details of share issuance to various parties and references the regulatory approval document number. The document is relatively short (1570 characters) and serves as a formal announcement of the approval and next steps rather than the full detailed report of the transaction or financial statements. It does not contain comprehensive financial data or detailed analysis but rather the regulatory approval notice and compliance instructions. Therefore, it fits best as a Capital/Financing Update (CAP) since it concerns issuance of shares and asset restructuring approval.
2017-06-02 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Chengdu Tianxing Instrument Co., Ltd. It discusses unusual stock price movements over specific trading days, the company's investigation into the cause, and confirms no undisclosed material information affecting the stock price. It references regulatory rules from the Shenzhen Stock Exchange and provides risk warnings to investors. The document is short (1110 characters) and focuses on stock price behavior and disclosure compliance, not on financial results, management changes, or other report types. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about stock trading irregularities and compliance, not a financial report or other specific filing type.
2017-05-22 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.